Today, the U.S. Supreme Court unanimously invalidated patents on two genes associated with hereditary breast and ovarian cancer in response to a lawsuit filed by the American Civil Liberties Union and the Public Patent Foundation.

This is a huge victory not only for those seeking to have their genes tested in order to make informed medical decisions but for civil liberties, scientific freedom, patients, and the future of personalized medicine.